Repetition Assessment for Speech and Language Disorders: A Study of the Logopenic Variant of Primary Progressive Aphasia

Primary Progressive Aphasia is a type of young onset dementia that is characterised by language impairment. Measuring disease progression and treatment response in PPAs is challenging. This study describes novel techniques for quantifying the quality of repetition in speech recordings and demonstrates the utility of the technique by using it to distinguish between healthy speakers and a subtype of PPA speakers.

In this paper, Redenlab collaborated with Takeda, MIT, University of Melbourne and Monash University.

Click here to find out more.

Related Post

  • Posted on 30 March, 2023
    Redenlab are partnering with Monash university, University of Melbourne, Eastern Health, and Invicta to deliver this world-first collaboration investigating neurofilament...
    • Posted on 30 March, 2023
      Angela Morgan, PhD, is a National Health and Medical Research Council Elizabeth Blackburn Fellow and leads the Speech and Language...
      • Posted on 30 March, 2023
        L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...